Anti-musk antibodies for use in treating neuromuscular disorders
US-2025051477-A1 · Feb 13, 2025 · US
argenx BV holds 7 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 7 |
| Recent patents | 5 |
| First publication | Sep 1, 2022 |
| Latest publication | Feb 13, 2025 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2025051477-A1 · Feb 13, 2025 · US
US-2024182590-A1 · Jun 6, 2024 · US
US-2024158492-A1 · May 16, 2024 · US
US-2024026010-A1 · Jan 25, 2024 · US
US-11713354-B2 · Aug 1, 2023 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2025051477-A1 · Feb 13, 2025 · US
US-2024182590-A1 · Jun 6, 2024 · US
US-2024158492-A1 · May 16, 2024 · US
US-2024026010-A1 · Jan 25, 2024 · US
US-11713354-B2 · Aug 1, 2023 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61K2039/505 | 7 |
| C07K2317/76 | 5 |
| C07K2317/52 | 3 |
| A61P21/00 | 3 |
| C07K2317/526 | 3 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 7 |
| Chemistry & Metallurgy | 7 |
| Physics | 3 |
Answers are generated from the same data shown on this page.